Cargando…
A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by SMN1 gene deletion/mutation. The drug nusinersen modifies SMN2 mRNA splicing, increasing the production of the full-length SMN protein. Recent studies have demonstrated the beneficial effects of nusinersen in patients with SMA, part...
Autores principales: | Shinohara, Masakazu, Niba, Emma Tabe Eko, Wijaya, Yogik Onky Silvana, Takayama, Izumi, Mitsuishi, Chisako, Kumasaka, Sakae, Kondo, Yoichi, Takatera, Akihiro, Hokuto, Isamu, Morioka, Ichiro, Ogiwara, Kazutaka, Tobita, Kimimasa, Takeuchi, Atsuko, Nishio, Hisahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510215/ https://www.ncbi.nlm.nih.gov/pubmed/33072999 http://dx.doi.org/10.3390/ijns5040041 |
Ejemplares similares
-
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis
por: Niba, Emma Tabe Eko, et al.
Publicado: (2021) -
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
por: Wijaya, Yogik Onky Silvana, et al.
Publicado: (2022) -
Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots
por: Wijaya, Yogik Onky Silvana, et al.
Publicado: (2021) -
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
por: Niba, Emma Tabe Eko, et al.
Publicado: (2022) -
Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots
por: Wijaya, Yogik Onky Silvana, et al.
Publicado: (2020)